Jiangsu Cowin Biotech Co Ltd
SSE:688426
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| CN |
J
|
Jiangsu Cowin Biotech Co Ltd
SSE:688426
|
2.9B CNY |
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
386.2B USD |
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
196.7B USD |
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
185.2B USD |
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
116.4B USD |
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.9B USD |
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
87.9B AUD |
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43.9B EUR |
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Market Distribution
| Min | -409 046.1% |
| 30th Percentile | -1.4% |
| Median | 4.2% |
| 70th Percentile | 10.3% |
| Max | 876.4% |
Other Profitability Ratios
Jiangsu Cowin Biotech Co Ltd
Glance View
Jiangsu Cowin Biotech Co., Ltd. engages in the provision of molecular testing services as well as the research and development of molecular testing products. The company is headquartered in Taizhou, Jiangsu and currently employs 603 full-time employees. The company went IPO on 2022-10-25. The firm is also in the business of molecular testing services. Molecular detection products include molecular detection raw materials enzymes, nucleic acid preservation reagents, nucleic acid extraction and purification reagents and molecular diagnostic kits. The firm's products are exported to the United States, Peru, Germany and other countries and regions.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Jiangsu Cowin Biotech Co Ltd is -95.3%, which is below its 3-year median of -93.5%.
Over the last 3 years, Jiangsu Cowin Biotech Co Ltd’s Operating Margin has decreased from 44% to -95.3%. During this period, it reached a low of -176.3% on Sep 30, 2024 and a high of 44% on Aug 30, 2022.
